Genmab nominates Eli Lilly veteran as board member
Genmab has nominated a successor to Jonathan Peacock, who stepped down from the company’s board of directors last year. The appointee is a woman with more than 24 years of experience at Eli Lilly.
by marketwire, translated by daniel pedersen
Genmab proposes Elizabeth O’Farrell be elected as a member of the board of directors at the company’s upcoming annual general meeting on March 29, a press release announces.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Genmab receives orphan drug designation from FDA
For subscribers
Genmab appoints two new executives
For subscribers
